NCT01953029

Brief Summary

The objective of our work to determine the mechanisms of myocardial infarction in women without obstructive coronary artery disease.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2013

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 23, 2013

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 30, 2013

Completed
2 months until next milestone

Study Start

First participant enrolled

December 1, 2013

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2016

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2018

Completed
Last Updated

September 30, 2013

Status Verified

September 1, 2013

Enrollment Period

2.8 years

First QC Date

September 23, 2013

Last Update Submit

September 25, 2013

Conditions

Myocardial Infarction

Outcome Measures

Primary Outcomes (1)

  • MORTALITY

    1 YEAR

Study Arms (1)

non obstructive coronary disease

non obstructive coronary disease

Procedure: cardiac imajing

Interventions

cardiac imajingPROCEDURE

Cardiac MRI

non obstructive coronary disease

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Women with myocardial infarction

You may qualify if:

  • Women ≥ 18 years old, not pregnant
  • with acute non ST elevation myocardial infarction (admitted within 12 hours from beginning of symptoms)
  • who are candidates for coronary arteriography during the hospitalization. -

You may not qualify if:

  • \*Women with troponin elevation caused by other causes -

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rambam Heath Care Campus

Haifa, 9602, Israel

Location

MeSH Terms

Conditions

Myocardial Infarction

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosis

Study Officials

  • Miry Blich, MD

    Rambam Health Care Campus

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Miry Blich, MD

CONTACT

972-4-8543478m_blich@rambam.health.gov.il

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Cardiologist

Study Record Dates

First Submitted

September 23, 2013

First Posted

September 30, 2013

Study Start

December 1, 2013

Primary Completion

October 1, 2016

Study Completion

October 1, 2018

Last Updated

September 30, 2013

Record last verified: 2013-09

Locations

IL(1)